Impact of the disclosure of amyloid‐PET results to patients with subjective cognitive decline: the AMYPAD Diagnostic and Patient Management Study (DPMS)

Authors :: Giovanni B. Frisoni
Andrew W. Stephens
Marta Félez‐Sánchez
Frank Jessen
Lean Lee
Frederik Barkhof
Julien Delrieu
Daniele Altomare
Léa Poitrine
Christian Moro
Claus M Escher
Agneta Nordberg
Rossella Gismondi
Ho‐Yun Lee
Sonia Plaza Wuthrich
José Luis Molinuevo
Laure Saint-Aubert
Philip Scheltens
Isadora Lopes Alves
Gill Farrar
Jean-François Démonet
Lyduine Collij
Zuzana Walker
Source :: Alzheimer's & Dementia. 16
Publication Year :: 2020
Publisher :: Wiley, 2020.

Subjects :: Epidemiology
business.industry
Health Policy
Amyloid pet
Patient management
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Developmental Neuroscience
Neuroimaging
Medicine
Neurology (clinical)
Geriatrics and Gerontology
Cognitive decline
business
Neuroscience
Brain aging

Full Text Access

Tools